Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BM32 Dose Finding in Grass Pollen Allergy
NCT01445002Phase 2Completed
- Sponsor
- Biomay AG
- Start
- Oct 2011
- Primary completion
- Mar 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of BM32 in allergic rhinitis (AR), sponsored by Biomay AG. Started Oct 2011; status: completed.
02
Drugs
BM32
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01445002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01445002.